两种皮试试剂在肺结核密切接触者筛查中的应用研究

贺晨耘, 姜虹

安徽预防医学杂志 ›› 2024, Vol. 30 ›› Issue (5) : 356-360.

PDF(838 KB)
PDF(838 KB)
安徽预防医学杂志 ›› 2024, Vol. 30 ›› Issue (5) : 356-360. DOI: 10.19837/j.cnki.ahyf.2024.05.003
论著

两种皮试试剂在肺结核密切接触者筛查中的应用研究

  • 贺晨耘1, 姜虹2
作者信息 +

Research on the application of two skin test reagents in screening close contacts of pulmonary tuberculosis

  • HE Chenyun1, JIANG Hong 2
Author information +
文章历史 +

摘要

目的 在肺结核密切接触者中,以γ-干扰素释放试验(IGRA)为标准,评估使用重组结核杆菌融合蛋白(EC)和结核菌素纯蛋白衍生物(PPD)两种试剂进行皮试的筛查效能及经济效益,为后续学校肺结核筛查工作提供参考依据。方法 将某次肺结核患者的密接人群随机分为EC组和PPD组,以IGRA为标准判断EC或PPD的筛查结果,3个月后完成二次筛查,PPD、EC以及IGRA结果阴性者再次重复该检测。计算两次筛查后EC、PPD试验的灵敏度、特异度、正确指数、Kappa值、预测值和ROC曲线下面积,并分析两者的成本-效果比,使用SPSS 25.0进行统计分析。结果 共筛查肺结核密切接触者491人,脱落9人,EC组239人,PPD组243人。两次筛查后EC组潜伏感染率为4.60%,灵敏度为66.67%,特异度为98.68%,正确指数为97.07%,阳性预测值为72.72%,阴性预测值为98.25%,Kappa值为0.680,ROC曲线下面积为 0.827;PPD组的潜伏感染率为18.93%,灵敏度为69.23%,特异度为83.91%,正确指数为83.13%,阳性预测值为19.57%,阴性预测值97.97%,Kappa值为0.242,ROC曲线下面积为 0.766。EC组每百人的筛查费用较PPD组少,使用成本-效果比(效果为潜伏性结核感染)评估时,EC组高于PPD组;使用皮试和IGRA均阳性的人数作为效果评估时,EC组低于PPD组。仅以皮试结果观察,EC组需要预防性治疗人数为11人(占4.60%) ,PPD组为27人(占11.11%)。结论 在筛查肺结核密接者潜伏性感染时,相较于PPD,EC特异度高,与IGRA检测结果一致性较好。同时,EC可以减少因PPD假阳性而增加的预防性治疗的人数,虽在经济效益方面仍存在争议,但不失为一种较好的皮试方法,具有一定的推广价值。

Abstract

Objective The screening efficacy and economic benefits of using recombinant mycobacterium tuberculosis fusion protein (EC) or purified protein derivative of tuberculin (PPD) as skin tests were evaluated in close contacts with pulmonary tuberculosis using interferon-gamma release assays (IGRA),providing a reference for subsequent school tuberculosis screening work. Methods The close contacts of tuberculosis patients at a given time was randomly divided into EC group and PPD groups.IGRA was applied as the standard to determine the screening results of EC and PPD.The second screening was completed 3 months later,and the test was repeated again for those with negative PPD,EC,and IGRA results.Calculate the sensitivity,specificity,accuracy index,Kappa value,predictive value,and area under the ROC curve of EC and PPD tests after the two screenings,and analyze their cost-effectiveness ratio.Statistical analyses was conducted using SPSS 25.0. Results A total of 491 close contacts with tuberculosis were screened,9 were shed,239 in the EC group and 243 in the PPD group.After two screening,the latent infection rate of EC group was 4.60%,the sensitivity was 66.67%,the specificity was 98.68%,the correct index was 97.07%,the positive predictive value was 72.72%,the negative predictive value was 98.25%,the Kappa value was 0.680,and the area under the ROC curve was 0.827.The latent infection rate of PPD group was 18.93%,the sensitivity was 69.23%,the specificity was 83.91%,the correct index was 83.13%,the positive predictive value was 19.57%,and the negative predictive value was 97.97%,the Kappa value was 0.242,and the area under the ROC curve was 0.766.The screening cost per hundred people in the EC group was lower than that in the PPD group.When evaluating the cost-effectiveness ratio (effect was latent tuberculosis infection),it was higher in the EC group than that in the PPD group.When evaluating the effect using the number of people who were positive for both skin tests and IGRA,it was lower in the EC group than that in the PPD group.Based solely on the results of the skin test,11 patients (4.60%) in the EC group required preventive treatment,while 27 patients (11.11%) in the PPD group. Conclusion Compared to PPD,EC has higher specificity and better consistency with IGRA detection results in screening for latent infections in close contacts of pulmonary tuberculosis.At the same time,EC can reduce the number of people receiving preventive treatment due to false positive of PPD .Although it is still controversial in terms of economic benefits,it is still a better method of skin test and has some value for dissemination.

关键词

重组结核杆菌融合蛋白 / 结核菌素试验 / 潜伏性结核感染

Key words

Recombinant mycobacterium tuberculosis fusion protein / Purified protein derivative of tuberculin / Latent tuberculosis infection

引用本文

导出引用
贺晨耘, 姜虹. 两种皮试试剂在肺结核密切接触者筛查中的应用研究[J]. 安徽预防医学杂志. 2024, 30(5): 356-360 https://doi.org/10.19837/j.cnki.ahyf.2024.05.003
HE Chenyun, JIANG Hong. Research on the application of two skin test reagents in screening close contacts of pulmonary tuberculosis[J]. Anhui Journal of Preventive Medicine. 2024, 30(5): 356-360 https://doi.org/10.19837/j.cnki.ahyf.2024.05.003
中图分类号: R521   

参考文献

[1] World Health Organization.Global tuberculosis report 2023[R].Geneva:World Health Organization,2023:1-75.
[2] 张婷,杨眉,吴成果,等.重组结核分枝杆菌融合蛋白在学校结核病筛查中的应用[J].预防医学情报杂志,2021,37(11):1609-1613.
[3] 张赛男,杨美霞,蔡晓峰,等.2020—2022年上海市徐汇区学校结核病密切接触者潜伏感染现状[J].上海预防医学,2023,35(12):1223-1226.
[4] 周林,初乃惠,陆伟.高危人群结核分枝杆菌潜伏感染检测及预防性治疗专家共识[J].中国防痨杂志,2021,43(9):874-878.
[5] World Health Organization.WHO consolidated guidelines on tuberculosis: module 1 preven-tion tuberculosis preventive treatment[M].Geneva:World Health Organization,2020.
[6] Pai M,Zwerling A,Menzies D.Systematic review:t-cell-based assays for the diagnosis of latent tuberculosis infection:an update[J].Ann Intern Med,2008,149(3):177-184.
[7] O’Garra A,Redford PS,McNab FW,et al.The immune response in tuberculosis[J].Annu Rev Immunol,2013,31:475-527.
[8] 上海市防痨协会,中国防痨协会青年理事会,《中国防痨杂志》编辑委员会.学校结核病疫情流行病学调查和现场处置专家共识[J].中国防痨杂志,2019,41(1):9-13.
[9] 卢水华,陆伟.重组结核杆菌融合蛋白(EC)临床应用专家共识[J].中国防痨杂志,2020,42(8):761-768.
[10] He Y,Cao X,Guo T,et al.Serial testing of latent tuberculosis infection in patients with diabetes mellitus using interferon-gamma release assay,tuberculin skin test,and creation tuberculin skin test[J].Front Public Health,2022,10:1025550.
[11] Lu P,Wu K,Zhou H,et al.Evaluation of ESAT6-CFP10 skin test for Mycobacterium tuberculosis infection among persons living with HIV in China[J].Journal of Clinical Microbiology,2023,61(4):1-10.
[12] Lu P,Xu J,Wang R,et al.Diagnostic performance of a novel ESAT6-CFP10 skin test for tuberculosis infection in school tuberculosis outbreak in China[J].Front Public Health,2023,11:1259106.
[13] 倪晓凤,刁莎,何思颐,等.重组结核杆菌融合蛋白的临床综合评价[J].中国药房,2023,34(4):391-396.
[14] 包训迪,王舒,张威,等.实验室检测在学校结核病疫情处置中的应用[J].安徽预防医学杂志,2020,26(5):375-376+389.
[15] 张瑜,卢鹏,陆伟,等.潜伏结核感染三种检测方法比较的研究进展[J].中国热带医学,2022,22(5):477-482.
[16] 苏倩,汪清雅,张婷,等.重组结核分枝杆菌融合蛋白皮肤试验与TST在学校结核潜伏感染筛查中的比较[J].中国感染控制杂志,2023,22(5):547-551.
[17] World Health Organization.WHO consolidated guidelines on tuberculosis:module 3:diagnosis–Tests for tuberculosis infection[J].2022.
[18] 程晓,陈哲,焦雪峰,等.重组结核杆菌融合蛋白(EC)用于诊断结核分枝杆菌感染的有效性和安全性系统评价[J].中国防痨杂志,2022,44(9):917-926.

PDF(838 KB)

Accesses

Citation

Detail

段落导航
相关文章

/